Weight gain in children on oxcarbazepine monotherapy

Highlights • Oxcarbazepine significantly increased body weight in children with epilepsy. • The oxcarbazepine induced weight gain was similar to that observed by valproate. • Linear growth was not affected by oxcarbazepine or valproate therapy

Saved in:
Bibliographic Details
Published in:Epilepsy research 2016-05, Vol.122, p.110-113
Main Authors: Garoufi, Anastasia, Vartzelis, George, Tsentidis, Charalambos, Attilakos, Achilleas, Koemtzidou, Evangelia, Kossiva, Lydia, Katsarou, Eustathia, Soldatou, Alexandra
Format: Article
Language:English
Subjects:
Adolescent
Anticonvulsants - adverse effects
Anticonvulsants - therapeutic use
Antiepileptic drugs
Body Mass Index
Carbamazepine - adverse effects
Carbamazepine - analogs & derivatives
Carbamazepine - therapeutic use
Child
Child, Preschool
Epilepsy
Epilepsy - drug therapy
Female
Humans
Linear growth
Male
Neurology
Obesity
Prospective Studies
Valproate
Valproic Acid - adverse effects
Valproic Acid - therapeutic use
Weight Gain - drug effects
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Highlights • Oxcarbazepine significantly increased body weight in children with epilepsy. • The oxcarbazepine induced weight gain was similar to that observed by valproate. • Linear growth was not affected by oxcarbazepine or valproate therapy
ISSN:0920-1211
1872-6844
DOI:10.1016/j.eplepsyres.2016.03.004